肾移植术后合并急性心梗患者的药学监护  

Postoperative pharmaceutical care of patients with acute myocardial infarction complication after renal transplantation

作　　者：侯冠昕[1] 王丹蕾[1] 党大胜[1] 逯艳姝[1] 史国兵[1] 赵庆春[1] 

机构地区：[1]沈阳军区总医院,沈阳110840

出　　处：《实用药物与临床》2013年第9期836-838,共3页Practical Pharmacy and Clinical Remedies

摘　　要：目的探讨临床药师对特殊生理状态患者的药学监护方法及角度,从而为临床合理用药提供参考。方法对1例肾移植术后14年合并急性非ST段抬高心肌梗死患者从药物选择、相互作用、代谢、排泄等方面进行全程的药学监护,为医师的药物治疗提供合理化用药建议。结果通过本次药学监护,对处于特殊生理状态同时使用抗免疫排斥方案的患者的用药方案有了新的认识,在药师的积极参与下患者平安出院。结论临床药师参与临床药物治疗过程,为患者制订个体化的治疗方案,可以有效保障患者用药安全,提高个体化水平。Objective To provide reference for clinical rational use of drugs through the investigation of the methods and points of a pharmaceutical care about a special physiological state patient.Methods The clinical pharmacist offer the entire pharmaceutical care including drug selection,interaction,metabolism,excretion to the patients who suffered from acute non-ST-segment elevation myocardial infarction with a kidney transplantation 14 years ago,for the rational drug using recommendations of the physician medication.Results With the active participation of the pharmacists,the patients safely discharged from hospital,and we obtained a newunderstanding of the drug using plan for the patients in a special physiological state who were under the anti-immune rejection treatment from the pharmaceutical care.Conclusion The results indicate that the clinical pharmacists participat in clinical drug treatment process for patients to develop individualized treatment programs which can be effective in protecting the safety of the drug use of patients to improve the individual drug using level.

关 键 词：急性心梗 肾移植术后 临床药师 药学监护 

分 类 号：R699[医药卫生—泌尿科学] R542.22[医药卫生—外科学]